Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Atsushi Goto¹, Hiroshi Noto², Mitsuhiko Noda³, Kohjiro Ueki⁴, Masato Kasuga⁵, Naoko Tajima⁶, Ken Ohashi⁷, Ryuichi Sakai⁸, Shoichiro Tsugane⁹, Nobuyuki Hamajima¹⁰, Kazuo Tajima¹¹, Kohzoh Imai¹², Hitoshi Nakagama¹³

Affiliations

¹ 1Tokyo Women's Medical University, Tokyo, Japan.
² 2St. Luke's International Hospital, Tokyo, Japan.
³ 3Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
⁴ 4Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
⁵ 5National Center for Global Health and Medicine, Tokyo, Japan.
⁶ 6Jikei University School of Medicine, Tokyo, Japan.
⁷ 7Department of General Internal Medicine, Dentistry, and Oncologic Emergencies, National Cancer Center Hospital, Tokyo, Japan.
⁸ 8Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan.
⁹ 9National Cancer Center Research Center for Cancer Prevention and Screening, Tokyo, Japan.
¹⁰ 10Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹¹ 11Department of Public Health and Occupational Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
¹² 12Center for Antibody and Vaccine Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
¹³ 13National Cancer Center Research Institute, Tokyo, Japan.

PMID: 30603237
PMCID: PMC6224904
DOI: 10.1007/s13340-016-0257-z

Practice Guideline

Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Atsushi Goto et al. Diabetol Int. 2016.

. 2016 Mar 7;7(1):12-15.

doi: 10.1007/s13340-016-0257-z. eCollection 2016 Mar.

Authors

Affiliations

¹ 1Tokyo Women's Medical University, Tokyo, Japan.
² 2St. Luke's International Hospital, Tokyo, Japan.
³ 3Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
⁴ 4Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
⁵ 5National Center for Global Health and Medicine, Tokyo, Japan.
⁶ 6Jikei University School of Medicine, Tokyo, Japan.
⁷ 7Department of General Internal Medicine, Dentistry, and Oncologic Emergencies, National Cancer Center Hospital, Tokyo, Japan.
⁸ 8Department of Biochemistry, Kitasato University School of Medicine, Sagamihara, Japan.
⁹ 9National Cancer Center Research Center for Cancer Prevention and Screening, Tokyo, Japan.
¹⁰ 10Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
¹¹ 11Department of Public Health and Occupational Medicine, Mie University Graduate School of Medicine, Tsu, Japan.
¹² 12Center for Antibody and Vaccine Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
¹³ 13National Cancer Center Research Institute, Tokyo, Japan.

PMID: 30603237
PMCID: PMC6224904
DOI: 10.1007/s13340-016-0257-z

Abstract

The Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer published its first report in July 2013 on the epidemiological assessment of the associations of diabetes with cancer risk/prognosis, the common risk factors for diabetes and cancer, and cancer risk associated with diabetes treatment The JDS/JCA Joint Committee continued its work to assess the role of glycemic control in the development of cancer in patients with diabetes. This review shows that high-quality evidence examining the association between glycemic control and cancer risk is lacking.

Keywords: Cancer; Diabetes; Glucose control; HbA1c; Observational studies; Randomized controlled trials.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethical standardsHiroshi Noto received honoraria for manuscripts from Eli Lilly Japan K.K. Mitsuhiko Noda received scholarship grants from Takeda Pharmaceutical Company Limited and AstraZeneca K. K. Kohjiro Ueki received speaker honoraria from MSD K.K, scholarship grants from Takeda Pharmaceutical Company Limited, Daiichi Sankyo Co., Ltd., Ono Pharmaceutical Co., Ltd., Astellas Pharma Inc., Sanofi K. K, Novo Nordisk Pharma Ltd., Eli Lilly Japan K.K, MSD K.K, Boehringer Ingelheim, Mitsubishi-Tanabe Pharma Corporation and courses endowed by MSD K.K, Boehringer Ingelheim and Novo Nordisk Pharma Ltd. Naoko Tajima received speaker honoraria from Astellas Pharma Inc., MSD K.K, Kissei Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly Japan K.K, Boehringer Ingelheim and Novo Nordisk Pharma Ltd. Nobuyuki Hamajima received scholarship grants from Sugi Drugstore Co. Ltd. Kohzoh Imai received research grants from DeNA Life Science. Inc. Hitoshi Nakagama received research grants from Shimadzu Corporation and BioMimetics Sympathies Inc. Atsushi Goto, Masato Kasuga, Ken Ohashi, Ryuichi Sakai, Shoichiro Tsugane and Kazuo Tajima declare that they have no conflict of interest.

References

1. Goto A, Noto H, Noda M, et al. Report of the JDS/JCA Joint Committee on Diabetes and Cancer, Second Report. J Japan Diabetes Soc. 2016;59(3):174–177.
1. Kasuga M, Ueki K, Tajima N, et al. Report of the JDS/JCA Joint Committee on Diabetes and Cancer. Diabetol Int. 2013;4(2):81–96. doi: 10.1007/s13340-013-0121-3. - DOI - PMC - PubMed
1. Noto H, Tsujimoto T, Sasazuki T, Noda M. Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract. 2011;17(4):616–628. doi: 10.4158/EP10357.RA. - DOI - PubMed
1. Sasazuki S, Charvat H, Hara A, et al. Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. Cancer Sci. 2013;104(11):1499–1507. doi: 10.1111/cas.12241. - DOI - PMC - PubMed
1. Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607. doi: 10.1136/bmj.g7607. - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Affiliations

Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on Diabetes and Cancer, Second Report

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

LinkOut - more resources

Full Text Sources